Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
Authors
Keywords
-
Journal
BRAIN
Volume 139, Issue 12, Pages 3217-3236
Publisher
Oxford University Press (OUP)
Online
2016-09-28
DOI
10.1093/brain/aww238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies
- (2016) Maria Xilouri et al. MOVEMENT DISORDERS
- Molecular Determinants of α-Synuclein Mutants’ Oligomerization and Membrane Interactions
- (2015) Igor F. Tsigelny et al. ACS Chemical Neuroscience
- Definition of a Molecular Pathway Mediating -Synuclein Neurotoxicity
- (2015) J. Burre et al. JOURNAL OF NEUROSCIENCE
- Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
- (2015) Simona Eleuteri et al. NEUROBIOLOGY OF DISEASE
- Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity
- (2015) Daniel Ysselstein et al. NEUROBIOLOGY OF DISEASE
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
- (2014) Edward Rockenstein et al. BRAIN
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
- (2014) Gergely Tóth et al. PLoS One
- Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
- (2014) B. G. Wilhelm et al. SCIENCE
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
- (2014) Mustafa T. Ardah et al. Frontiers in Aging Neuroscience
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α-Synuclein
- (2013) Dora Games et al. AMERICAN JOURNAL OF PATHOLOGY
- Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines
- (2013) Beatriz Alvarez-Castelao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor
- (2013) Ronit Shaltiel-Karyo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization
- (2013) Alireza Roostaee et al. Molecular Neurodegeneration
- The genetics of Parkinson's disease: Progress and therapeutic implications
- (2013) Andrew B. Singleton et al. MOVEMENT DISORDERS
- Lysosomal impairment in Parkinson's disease
- (2013) Benjamin Dehay et al. MOVEMENT DISORDERS
- Update on novel familial forms of Parkinson's disease and multiple system atrophy
- (2013) Shinsuke Fujioka et al. PARKINSONISM & RELATED DISORDERS
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
- (2012) Nunilo Cremades et al. CELL
- Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation
- (2012) Igor F. Tsigelny et al. FEBS Journal
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
- (2012) Kelvin C. Luk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Accumulation of Toxic -Synuclein Oligomer within Endoplasmic Reticulum Occurs in -Synucleinopathy In Vivo
- (2012) E. Colla et al. JOURNAL OF NEUROSCIENCE
- α-Synuclein Oligomers: an Amyloid Pore?
- (2012) Martin T. Stöckl et al. MOLECULAR NEUROBIOLOGY
- Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD
- (2012) Brian Spencer et al. MOLECULAR THERAPY
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- Baicalein Inhibits Formation of α-Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation
- (2011) Jia-Hong Lu et al. CHEMBIOCHEM
- Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein
- (2011) Ken Nakamura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prion-like transmission of protein aggregates in neurodegenerative diseases
- (2010) Patrik Brundin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell-to-cell transmission of non-prion protein aggregates
- (2010) Seung-Jae Lee et al. Nature Reviews Neurology
- Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
- (2010) Leslie Crews et al. PLoS One
- In Vivo Imaging of α-Synuclein in Mouse Cortex Demonstrates Stable Expression and Differential Subcellular Compartment Mobility
- (2010) Vivek K. Unni et al. PLoS One
- Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
- (2010) Bart D. van Rooijen et al. PLoS One
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent -Synuclein Oligomer Formation and Rescue -Synuclein-Induced Toxicity
- (2009) P. Putcha et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Curcumin inhibits aggregation of α-synuclein
- (2008) Neeraj Pandey et al. ACTA NEUROPATHOLOGICA
- Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease
- (2008) Pazit Bar-On et al. JOURNAL OF NEUROCHEMISTRY
- Broken Helix in Vesicle and Micelle-Bound α-Synuclein: Insights from Site-Directed Spin Labeling-EPR Experiments and MD Simulations
- (2008) Marco Bortolus et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mechanism of alpha-synuclein oligomerization and membrane interaction: theoretical approach to unstructured proteins studies
- (2008) Igor F. Tsigelny et al. Nanomedicine-Nanotechnology Biology and Medicine
- Conformational Equilibria in Monomeric α-Synuclein at the Single-Molecule Level
- (2008) Massimo Sandal et al. PLOS BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started